We found an unexpected reduction of central memory CD8+ T cells, which reportedly play an important role in antitumor activity in cancer immunotherapy24,25, harboring CCR4 expression accompanied by Treg cell reduction after mogamulizumab administration; this indicates the importance of developing more specific Treg cell-targeted therapies. This evidence concerns the gene CCR4 and cancer.